摘要:
The invention provides compounds of the invention pharmaceutical compositions comprising a compound of the invention, processes for preparing compounds of the invention, intermediates useful for preparing compounds of the invention, and therapeutic methods for treating cancer and other topoisomerase mediated conditions.
摘要:
The invention provides compounds of the invention pharmaceutical compositions comprising a compound of the invention, processes for preparing compounds of the invention, intermediates useful for preparing compounds of the invention, and therapeutic methods for treating cancer and other topoisomerase mediated conditions.
摘要:
The present invention relates to triazine derivatives as cell adhesion inhibitors. The compounds of this invention can be useful inter alia, for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies, including inflammatory and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type I diabetes, multiple sclerosis, allograft rejection, psoriasis. The compounds can be used to formulate pharmacological compositions, and the methods of treating bronchial asthma, rheumatoid arthritis, multiple sclerosis, type I diabetes, psoriasis, allograft rejection, and other inflammatory and/or autoimmune disorders, using the compounds are also provided herein.
摘要:
An output buffer (500) is disclosed that includes an output driver circuit (508) having a first drive transistor (P504) for driving an output node (520) to a first logic level according the potential at a first pre-drive node (516), and a second drive transistor (N504) for driving the output node (520) to a second logic level according the potential at a second pre-drive node (518). The potential at the first pre-drive node (516) is established by a first standard pre-drive circuit (504) and a first phased pre-drive circuit (512). The potential at the second pre-drive node (518) is established by a second standard pre-drive circuit (506) and a second phased pre-drive circuit (514). In a low voltage mode of operation, where the rate of current drawn (di/dt) by the output driver circuit (508) is reduced, the standard and phased pre-drive circuits (504, 506, 512, 514) function together to drive their respective pre-drive nodes. In a high voltage mode of operation, where output driver circuit (508) di/dt is increased, the phased pre-drive circuits (512 and 514) are enabled a predetermined delay after the standard pre-drive circuits (504 and 506).
摘要:
A switching circuit can have a plurality of first signal lines of a programmable logic device, a plurality of second signal lines of the programmable logic device, and a plurality of switch elements. Each switch element can selectively couple one first signal line to a second signal line and include one or more switch junction field effect transistors (JFETs) having a first control gate separated from a second control gate by a channel region.
摘要:
Provided herein are macrolide derivatives that can be useful in treating or preventing inflammatory diseases. Also provided are pharmaceutical compositions comprising one or more macrolide derivatives optionally together with one or more pharmaceutically acceptable carriers, excipients, diluents or mixtures thereof, as well as methods for treating or preventing inflammatory diseases.
摘要:
The present invention relates to isoxazoline derivatives of structure Ia, which can be used as selective inhibitors of phosphodiesterase (PDE) type IV. Compounds disclosed herein can be useful in the treatment of CNS disorders, AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases especially in humans. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and their use as phosphodiesterase (PDE) type IV inhibitors. Formula (Ia)
摘要:
The present invention is directed to a method and device for ensuring patient continuity of care. One aspect of the present method includes providing to a patient a hand-held portable device that has at least a portion of the patient's medical record stored thereon. The patient can then carry the hand-held portable device on his person for access of the information thereon whenever necessary or desired.
摘要:
A delay-locked-loop (DLL) that has increased precision and a wide range of operation is formed by utilizing a chain of delay blocks to add or subtract a discreet amount of delay, and a voltage-controlled delay line (VCDL) to add or subtract a smaller amount of delay. The delay blocks allow the delayed clock signal to get close to the reference clock signal, while the VCDL allows the delayed clock signal to lock onto the reference clock signal.